Curvebeam Ai Ltd - Asset Resilience Ratio
Curvebeam Ai Ltd (CVB) has an Asset Resilience Ratio of 8.27% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Curvebeam Ai Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how Curvebeam Ai Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Curvebeam Ai Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Curvebeam Ai Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CVB stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.04 Million | 8.27% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$5.04 Million | 8.27% |
Asset Resilience Insights
- Limited Liquidity: Curvebeam Ai Ltd maintains only 8.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Curvebeam Ai Ltd Industry Peers by Asset Resilience Ratio
Compare Curvebeam Ai Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Curvebeam Ai Ltd (2023–2025)
The table below shows the annual Asset Resilience Ratio data for Curvebeam Ai Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 8.27% | AU$5.04 Million ≈ $3.57 Million |
AU$60.98 Million ≈ $43.15 Million |
-1.92pp |
| 2024-06-30 | 10.18% | AU$6.45 Million ≈ $4.56 Million |
AU$63.33 Million ≈ $44.81 Million |
+1.78pp |
| 2023-06-30 | 8.41% | AU$5.16 Million ≈ $3.65 Million |
AU$61.36 Million ≈ $43.42 Million |
-- |
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot … Read more